LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia

Janani Ravikrishnan, Deepa Sampath, Xiaokui Mo et al.|Haematologica|2024

Cited by 12